Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview
The Latin America pharmaceutical contract manufacturing and research services market size was valued at USD 19.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. Drug shortfall, tighter budgets, rising competition, patent expiration, and insufficient resources are some of the major factors boosting growth in the market. The time- and cost-saving benefits associated with the implementation of outsourcing are contributing to market growth. The key players are consistently capitalizing on technology, infrastructure, and personnel to gain a bigger share of the outsourcing revenue. Moreover, an increase in collaborations between pharmaceutical companies and outsourcing companies for developing COVID-19 treatments is boosting the market growth.
The ongoing COVID-19 pandemic has positively impacted the contract manufacturing market. As the development of mRNA vaccines and subsequent manufacturing at a global scale to respond to the COVID-19 pandemic represents a leap forward in the production facilities. With increased focus on CDMO activity for commercial supply, the demand for outsourced early phase development services and technology is growing in line with this new generation of molecules.
Moreover, new product launches and novel drug delivery mechanisms that are expected to enter the market in record timelines are anticipated to drive outsourcing demand. The key players entered into strategic partnerships for the development of COVID-19 treatments. For instance, in May 2020, Lonza announced a strategic collaboration agreement for ten years with Moderna to empower the manufacture of Spikevax COVID-19 vaccine and further Moderna Services in the future.
Gather more insights about the market drivers, restrains and growth of the Latin America Pharmaceutical Contract Manufacturing & Research Services market
Furthermore, the shift from cost control to value-added solutions, the introduction of novel technologically equipped facilities, and risk-sharing between pharma and CMOs are expected to serve as drivers. Companies have started financing efforts to meet the snowballing demand for biological drugs, which in turn, leads to a surge in the development of pharmaceutical products. This steady commercial success of biopharmaceuticals is expected to accelerate the growth of the Latin America pharmaceutical contract manufacturing & research services market over the forecast period.
Biopharmaceuticals Manufacturing is recognized as a leading sector in terms of growth potential. Many healthcare entities believe that this sector would be one of the top 10 revenue generators in the forthcoming years. Moreover, the market players are making continuous efforts for the development of this sector to meet the increasing demand for bio-based pharmaceuticals, which in turn, is anticipated to result in a surge of CMOs for biopharmaceutical production. This healthy growth of biopharmaceuticals has resulted in the development of a large Service pipeline.
Understanding the cost-effectiveness associated with contract manufacturing, many firms have begun to outsource parts of their biopharmaceutical manufacturing to contract manufacturers. Furthermore, in-house R&D at biopharmaceutical majors is no longer the sole source of successful innovation in the industry, with novel molecules discovered by small-to-mid capital companies before being acquired by established players. As a consequence, CROs have increasingly begun to highlight contract wins with such smaller biotech entities as an important driver of sustainability in volumes.
Latin American companies are enhancing their global market presence by investing efforts in the modification and expansion of domestic specialty manufacturing facilities as well as focusing on worldwide partnerships. On the other hand, the expansion of international and well-established companies, such as Pharmaceutical Product Development Inc (PPD) and QuintilesIMS, in countries like Brazil, Mexico, Argentina, and Chile is expected to fuel growth in Latin American pharmaceutical contract manufacturing & research services market. These countries are perceived to have great potential for pharmaceutical development.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Anastomosis Devices Market - The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030.
- Skincare Devices Market - The global skincare devices market size was valued at USD 12.5 billion in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030.
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Segmentation
Grand View Research has segmented the Latin America pharmaceutical contract manufacturing & research services market based on services and country:
Latin America Pharmaceutical Contract Manufacturing & Research Services Outlook (Revenue, USD Million, 2018 - 2030)
- Manufacturing
- API/Bulk Drugs
- Advanced Drug Delivery Formulations Packaging
- Packaging
- Finished Dose Formulations
- Solid Formulations
- Liquid Formulations
- Semi-solid Formulations
- Research
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
Latin America Pharmaceutical Contract Manufacturing & Research Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies profiled:
Some prominent players in the Latin America pharmaceutical contract manufacturing & research services market include:
- Boehringer Ingelheim GmbH
- Lonza
- Pfizer, Incorporated. (Pfizer CenterOne)
- Charles River Laboratories International, Inc
- Albany Molecular Research, Inc
- Covance, Inc. (LabCorp)
- QuintilesIMS
- Pharmaceutical Service Development, LLC
- Recipharm AB
- AbbVie, Inc.
Order a free sample PDF of the Latin America Pharmaceutical Contract Manufacturing & Research Services Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
